132 related articles for article (PubMed ID: 20007526)
1. Re: False-positive results in cancer epidemiology: a plea for epistemological modesty.
Cogliano V; Straif K
J Natl Cancer Inst; 2010 Jan; 102(2):134; author reply 134-5. PubMed ID: 20007526
[No Abstract] [Full Text] [Related]
2. False-positive results in cancer epidemiology: a plea for epistemological modesty.
Boffetta P; McLaughlin JK; La Vecchia C; Tarone RE; Lipworth L; Blot WJ
J Natl Cancer Inst; 2008 Jul; 100(14):988-95. PubMed ID: 18612135
[TBL] [Abstract][Full Text] [Related]
3. Re: False-positive results in cancer epidemiology: a plea for epistemological modesty.
Clapp RW; Kriebel D
J Natl Cancer Inst; 2009 Feb; 101(3):211-2; author reply 213-4. PubMed ID: 19176465
[No Abstract] [Full Text] [Related]
4. 2,3,7,8-Tetrachlorodibenzo-p-dioxin.
National Toxicology Program
Rep Carcinog; 2011; 12():396-8. PubMed ID: 21863101
[No Abstract] [Full Text] [Related]
5. Polychlorinated dibenzo-para-dioxins.
IARC Monogr Eval Carcinog Risks Hum; 1997; 69():33-343. PubMed ID: 9336729
[No Abstract] [Full Text] [Related]
6. Re: False-positive results in cancer epidemiology: a plea for epistemological modesty.
Crosignani P
J Natl Cancer Inst; 2009 Feb; 101(3):212-3; author reply 213-4. PubMed ID: 19176452
[No Abstract] [Full Text] [Related]
7. Acrylonitrile and cancer: a review of the epidemiology.
Cole P; Mandel JS; Collins JJ
Regul Toxicol Pharmacol; 2008 Dec; 52(3):342-51. PubMed ID: 18926871
[TBL] [Abstract][Full Text] [Related]
8. From testing to estimation: the problem of false positives in the context of carcinogen evaluation in the IARC monographs.
Demetriou CA; Straif K; Vineis P
Cancer Epidemiol Biomarkers Prev; 2012 Aug; 21(8):1272-81. PubMed ID: 22714739
[TBL] [Abstract][Full Text] [Related]
9. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD); "dioxin".
Rep Carcinog; 2004; 11():III241-3. PubMed ID: 21089963
[No Abstract] [Full Text] [Related]
10. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD); "dioxin".
National Toxicology Program
Rep Carcinog; 2002; 10():224-6. PubMed ID: 15340981
[No Abstract] [Full Text] [Related]
11. Receptor-mediated biological processes: implications for evaluating carcinogens.
Silbergeld E
Prog Clin Biol Res; 1994; 387():273-93. PubMed ID: 7972252
[No Abstract] [Full Text] [Related]
12. False positives in cancer epidemiology.
McLaughlin JK; Tarone RE
Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):11-5. PubMed ID: 23118145
[TBL] [Abstract][Full Text] [Related]
13. Arsenic, dioxin, and the promotional step in cancer creation.
Kayajanian GM
Ecotoxicol Environ Saf; 2000 Mar; 45(3):195-7. PubMed ID: 10702337
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cancer risks projected from animal bioassays to epidemiologic studies of acrylonitrile-exposed workers.
Ward CE; Starr TB
Regul Toxicol Pharmacol; 1993 Oct; 18(2):214-32. PubMed ID: 8278643
[TBL] [Abstract][Full Text] [Related]
15. Toxicology of the polychlorinated biphenyls, dibenzofurans and dibenzodioxins.
Iverson F; Grant DL
IARC Sci Publ; 1991; (108):5-29. PubMed ID: 1817109
[No Abstract] [Full Text] [Related]
16. Acrylonitrile.
Rep Carcinog; 2004; 11():III6-8. PubMed ID: 21089795
[No Abstract] [Full Text] [Related]
17. How serious is dioxin's cancer risk?
Cooney CM
Environ Sci Technol; 2001 May; 35(9):180A-181A. PubMed ID: 11355197
[No Abstract] [Full Text] [Related]
18. [Epidemiological risk assessment for chemical substances].
Becher H; Wahrendorf J
Zentralbl Hyg Umweltmed; 1995 Apr; 197(1-3):188-95. PubMed ID: 8579708
[TBL] [Abstract][Full Text] [Related]
19. Cancer dose--response assessment for acrylonitrile based upon rodent brain tumor incidence: use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity.
Kirman CR; Gargas ML; Marsh GM; Strother DE; Klaunig JE; Collins JJ; Deskin R
Regul Toxicol Pharmacol; 2005 Oct; 43(1):85-103. PubMed ID: 16099568
[TBL] [Abstract][Full Text] [Related]
20. Acrylonitrile.
National Toxicology Program
Rep Carcinog; 2002; 10():6-8. PubMed ID: 15317112
[No Abstract] [Full Text] [Related]
[Next] [New Search]
